Clinical Trials in San Antonio

Showing 81-100 of 12,572 trials

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

NCT07486934

The purpose of the study is to assess the efficacy, safety, and tolerability of zeleciment basivarsen (DYNE-101) for the treatment of myotonic dystrophy 1 (DM1).

Myotonic Dystrophy Type 1 (DM1)DM1Myotonic Dystrophy+2 more

Dyne Therapeutics150 participantsStarted Apr 2026

Atlanta, Georgia, United States • Hillsborough, North Carolina, United States • San Antonio, Texas, United States +2 more locations

RECRUITINGPhase 1/2< 1 mile

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

NCT07335497

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) (RP2D) in participants with locally advanced or metastatic solid tumors.

Locally Advanced / Metastatic Solid Tumors

Crescent Biopharma, Inc.290 participantsStarted Feb 2026

Denver, Colorado, United States • Orlando, Florida, United States • Sarasota, Florida, United States +7 more locations

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Find Trials by Condition in San Antonio

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

δ in Dementia Clinical Trials

Gastroschisis Outcomes of Delivery (GOOD) Study

A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

Confirm Rx Insertable Cardiac Monitor SMART Registry

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma

Study of SGN1 in Patients With Advanced Solid Tumor